Pralsetinib
Pralsetinib comes in 1 pill version in our database, in 1 strength, from 1 manufacturer. Check the imprint to tell them apart.
Pralsetinib pill images
100 mg 1 pill
What is Pralsetinib used for?
Pralsetinib is used for lung cancer.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
GAVRETO is indicated for the treatment of adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC) as detected by an FDA approved test.
RET Fusion-Positive Thyroid Cancer
GAVRETO is indicated for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic RET fusion-positive thyroid cancer who require systemic therapy and who are radioactive iodine-refractory (if radioactive iodine is appropriate).
This indication is approved under accelerated approval based on overall response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trial(s).
From the FDA-approved label on DailyMed (published Jan 28, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.